Researchers have developed a new model to track inflammation-driven blood clots that can cause complications in sickle cell ...

25), the late-breaking findings showed that 94.3% of patients achieved normal blood clotting and vessel repair ... and positive data from the randomized phase 1 trial data compared with placebo ...